Clinical Trials on Colitis,Ulcerative

Total 1970 results

Academisch Medisch Centrum - Universiteit van Amsterdam...
Galapagos NV

Active, not recruiting

Early Intestinal Ultrasound in Predicting Treatment Response to Filgotinib in Ulcerative Colitis (STEER)

Ulcerative Colitis

Netherlands
Ferring Pharmaceuticals

Completed

Assessment of 5-Aminosalicylic Acid Prescription Patterns and Treatment Outcomes in Patients With Ulcerative Colitis in Korea

Ulcerative Colitis

Korea, Republic of
Tampere University Hospital

Completed

Prognosis in UC After First Biological (biological)

Ulcerative Colitis
Ferring Pharmaceuticals

Completed

Induction and Maintenance of Remission With Pentasa as Ulcerative Colitis Treatment (IMPACT)

Ulcerative Colitis

Netherlands
Abivax S.A.
Orion Corporation, Orion Pharma

Active, not recruiting

Study Evaluating the Long-term Safety and Efficacy of ABX464 in Active Ulcerative Colitis

Ulcerative Colitis

Belgium
Bridge Biotherapeutics, Inc.
KCRN Research, LLC

Terminated

Efficacy and Safety of BBT-401-1S in Ulcerative Colitis

Ulcerative Colitis

United States
Centre Hospitalier Universitaire de Saint Etienne
Merck Sharp & Dohme LLC

Completed

Golimumab in Ulcerative Colitis (UC) Patients With Loss of Response (LOR) Followed by Dose Optimization (GOLILOR)

Ulcerative Colitis

France
Kaleido Biosciences

Completed

A Clinical Study to Assess the Effects of KB295 in Patients With Ulcerative Colitis (UC) on Gut Microbiota Structure and Function

Ulcerative Colitis

Ireland, United States
Shire

Completed

An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)

Ulcerative Colitis

Spain, United States, Korea, Republic of, Lebanon, Australia, Russian Federation, Romania, Hungary, Portugal, Israel, Italy, Turkey, Croatia, Belgium, Bulgaria, Germany, Netherlands, Poland, New Zealand, Argentina, United Kingdom, Greec... and more
Alimentiv Inc.
Alimentiv Translational Research Consortium

Terminated

Identification of Biomarkers of Janus Kinase Inhibitor Therapy in Patients With Ulcerative Colitis (PROPHETIC)

Ulcerative Colitis

Netherlands
Abivax S.A.

Active, not recruiting

Efficacy and Safety Study of ABX464 as Maintenance Therapy in Patients With Moderate to Severe Ulcerative Colitis

Ulcerative Colitis

Poland, Spain, France, Germany, Italy, Slovenia, Belgium, Canada, Belarus, Hungary, Czechia, Austria, United Kingdom, Serbia, Slovakia, Ukraine
University of Washington
University of Pennsylvania; UCB Pharma

Completed

Study of Cimzia for the Treatment of Ulcerative Colitis (UC CIMZIA)

Ulcerative Colitis

United States
LG Chem

Withdrawn

Efficacy and Safety of LC51-0255 in Subjects With Ulcerative Colitis

Ulcerative Colitis
Protagonist Therapeutics, Inc.

Terminated

Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis

Ulcerative Colitis

United States, Australia, Belgium, Bosnia and Herzegovina, Canada, Croatia, Czechia, Germany, Hungary, Korea, Republic of, Latvia, Netherlands, New Zealand, Poland, Russian Federation, Serbia, Ukraine
Bridge Biotherapeutics, Inc.
Covance

Terminated

Efficacy and Safety of Rectally Administered BBT-401-1S in Subjects With Ulcerative Colitis

Ulcerative Colitis

New Zealand
Celgene

Completed

Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis

Ulcerative Colitis

Korea, Republic of, United States, Belgium, Israel, Netherlands, Australia, Germany, Hungary, New Zealand, Italy, Canada, Bulgaria, Croatia, United Kingdom, Argentina, Austria, Belarus, Czechia, Georgia, Moldova, Republic of, Po... and more
Hoffmann-La Roche

Completed

A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors (HICKORY)

Ulcerative Colitis

Israel, Spain, United States, United Kingdom, Belgium, Korea, Republic of, Australia, Austria, France, Hungary, Italy, Netherlands, Canada, Germany, Poland, Brazil, Argentina, Czechia, Lithuania, Switzerland, Mexico, Denmark, Greece, ...
Abivax S.A.

Completed

Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis

Ulcerative Colitis

Belgium, Poland, Spain, France, Germany, Italy, Slovenia, Canada, Belarus, Hungary, Czechia, Austria, United Kingdom, Serbia, Slovakia, Ukraine, United States
Hoffmann-La Roche

Completed

A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors (HIBISCUS I)

Ulcerative Colitis

United States, Australia, Serbia, Hong Kong, Brazil, Bulgaria, Estonia, Poland, Russian Federation, Mexico, Ukraine, Argentina, France, Slovakia
Alimentiv Inc.
Abbott

Terminated

Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With Ulcerative Colitis (UC)

Ulcerative Colitis
The Cleveland Clinic

Completed

Evaluation of 3D Visualization for Total Colectomy (3Dvs2DforUC)

Ulcerative Colitis

United States
University of Zurich
Swiss National Science Foundation; The Broad Foundation

Completed

Anthocyanin Rich Extract (ACRE) in Patients With Ulcerative Colitis (ACRE)

Ulcerative Colitis

Switzerland
Najwa Elnachef

Completed

Optimal Fecal Microbiota Transplant Dosing for Mild to Moderate Ulcerative Colitis

Ulcerative Colitis

United States
Gilead Sciences
Galapagos NV

Completed

Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis (SELECTION)

Ulcerative Colitis

United States, Netherlands, Israel, Spain, Taiwan, Germany, Australia, Italy, Hong Kong, India, Singapore, Canada, Korea, Republic of, United Kingdom, New Zealand, Ireland, France, Poland, Japan, Switzerland, Croatia, Belgium, Malaysia and more
Arena Pharmaceuticals

Completed

Safety and Efficacy of Etrasimod (APD334) in Patients With Ulcerative Colitis

Ulcerative Colitis

United States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, France, Germany, Hungary, Israel, Korea, Republic of, Latvia, Lithuania, New Zealand, Poland, Romania, Russian Federation, Spain, Ukraine, United Kingdom
Emory University

Terminated

Melatonin and Ulcerative Colitis: A Pilot Clinical Trial

Ulcerative Colitis

United States
Ipsen

Completed

Study of the Effectiveness of ETIASA® (Sustained Release 5-Aminosalicylate) in Maintenance Treatment of Ulcerative Colitis (UC)

Ulcerative Colitis

China
Gilead Sciences

Completed

Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of GS-5745 (Andecaliximab) in Adults With Moderate to Severe Active Ulcerative Colitis

Ulcerative Colitis

United States, Belgium, Netherlands, Canada, Hungary, Moldova, Republic of, Romania
Pfizer

Withdrawn

Real World Study Of The Clinical Profile And Treatment Outcomes Of Advanced Therapies For Ulcerative Colitis In Portugal (READ-UC)

Ulcerative Colitis
University of California, Irvine
Wakunaga Pharmaceutical Co., Ltd.

Withdrawn

Effects of Probiotics in Patients With Ulcerative Colitis

Ulcerative Colitis

United States
Stanford University

Completed

Evaluating Safety and Efficacy of Herbal Treatment in Ulcerative Colitis (SA100)

Ulcerative Colitis

United States
Medical College of Wisconsin
Takeda

Terminated

Vedolizumab Monotherapy Vs Combination Therapy With Tacrolimus in UC (COVET)

Ulcerative Colitis

United States
Bausch Health Americas, Inc.

Completed

(CB-01-02/04) Extension Study of Budesonide Multi-Matrix System (MMX) 6 mg in Maintenance Of Remission In Patients With Ulcerative Colitis.

Ulcerative Colitis

United States, Canada
Genentech, Inc.

Completed

Study to Evaluate the Long-term Safety of Etrolizumab in Participants With Moderate to Severe Ulcerative Colitis

Ulcerative Colitis

United States, Israel, Belgium, Australia, Czechia, New Zealand, Canada, Spain, Germany, United Kingdom, Hungary
Cardiff and Vale University Health Board
Procter and Gamble

Completed

The Colitis Once Daily Asacol Study (CODA)

Ulcerative Colitis

United Kingdom
VSL Pharmaceuticals
Actial Farmaceutica S.r.l.

Terminated

PRObiotic VSL#3® for Maintenance of Clinical and Endoscopic REMission in Ulcerative Colitis (PROREM UC)

Ulcerative Colitis

Italy
Bausch Health Americas, Inc.

Completed

(CB-01-02/01) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis

Ulcerative Colitis

United States, Canada, India, Mexico
Bausch Health Americas, Inc.

Completed

New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis

Ulcerative Colitis

United States
AbbVie

Completed

A Prospective Non-interventional Multicenter Study to Evaluate the Effectiveness of Adalimumab in Korean Patients With Ulcerative Colitis (UC) and Identify Potential Predictors of Clinical Response in Routine Clinical Practice (EUREKA)

Ulcerative Colitis

Korea, Republic of
University of Miami
Broad Medical Research Program Crohn's and Colitis Foundation

Completed

Diet Study on Ulcerative Colitis

Ulcerative Colitis

United States
Connecticut Children's Medical Center
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Predicting Response to Standardized Pediatric Colitis Therapy (PROTECT)

Ulcerative Colitis

United States, Canada
Bausch Health Americas, Inc.

Completed

Randomized Placebo-Controlled Trial of Budesonide Multi-Matrix System (MMX®) 9 Milligrams (mg) in Participants With Ulcerative Colitis Currently on a 5-Aminosalicylic Acid (5-ASA)

Ulcerative Colitis

United States, Bulgaria, Canada, Czechia, Estonia, Hungary, Latvia, Lithuania, Poland, Russian Federation, Ukraine
Kyungpook National University Hospital
Celltrion

Terminated

Azathioprine Based on Endoscopy After Clinical Remission in Moderate to Severe Ulcerative Colitis (ACE)

Ulcerative Colitis

Korea, Republic of
Fakultas Kedokteran Universitas Indonesia

Unknown

Beta-1,3/1,6-D-Glucan Ganoderma Lucidum on Ulcerative Colitis

Ulcerative Colitis

Indonesia
Amgen

Completed

Abrilumab (AMG 181) in Adults With Moderate to Severe Ulcerative Colitis

Ulcerative Colitis

United States, Belgium, Canada, Denmark, Italy, Hungary, Germany, Switzerland, Netherlands, Australia, Russian Federation, Austria, France, United Kingdom, Czechia, Greece, Poland, Estonia, Latvia, Norway
Shandong University

Unknown

Development and Validation of a Deep Learning Algorithm to Evaluate Endoscopic Disease Activity of Ulcerative Colitis.

Ulcerative Colitis

China
AbbVie

Completed

Special Investigation in Patients With Ulcerative Colitis

Ulcerative Colitis
Takeda

Completed

Phase III Study of MLN0002 (300 mg) in the Treatment of Ulcerative Colitis

Ulcerative Colitis

Japan
Gilead Sciences

Terminated

Safety and Efficacy of Andecaliximab (GS-5745) in Adults With Moderately to Severely Active Ulcerative Colitis

Ulcerative Colitis

United States, Australia, France, Poland, Ukraine, Switzerland, Romania, Canada, Netherlands, Korea, Republic of, Belgium, Russian Federation, Taiwan, New Zealand, Hungary, United Kingdom, Bulgaria, Latvia, Czechia, Slovakia, Italy and more
Merck Sharp & Dohme LLC

Completed

Preference for a Prefilled Syringe or Smartject™ Device for Delivering Golimumab in Participants Suffering From Moderate-to-severe Ulcerative Colitis (MK-8259-027) (SMART)

Ulcerative Colitis

Clinical Trials on Colitis,Ulcerative

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations